Form D · Other
OncoRock Therapeutics Inc.
Little Rock, AR · CIK 0002092566
Offering snapshot reported Oct 29, 2025 · SEC filing
- Reported sold
- $125K Offering amount: $500K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 14, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 29, 2025 | Initial | $125,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-562387
Simple Agreement for Future Equity
Source: Form D, filed Oct 29, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Koss | Director, Executive |
| Alan Tackett | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
45 Ranch Ridge Road
Little Rock, AR, 72223
Little Rock, AR, 72223